Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-051148

10% owner sold 2,510 shares at $29.05 ($72,916)

From the SEC's structured data for this filing

Trades in this filing

UBS Oncology Impact Fund L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-11 Sale : show line 1 in the form −2,510 $29.05 $72,916 7,911,377 D
Open-market sales · 2,510 sh · avg $29.05 · $72,916
Loading xslF345X03/doc4.xml…